This contract expires in 336 days (Sep 27, 2027).

MAYO CLINIC - PHARMACOKINETIC AND BIOAVAILABILITY STUDIES IN RATS WITH INVESTIGATIONAL CANCER CHEMOTHERAPEUTIC AGENTS

PIID: 75N91026F00001Solicitation ID: TORFP PK-OALM-DIVISIONB-0

Signed Date: Sep 24, 2026Effective Date: Sep 28, 2026End Date: Closes in 336 days

Award $

$54K

Vendor

MAYO CLINIC

NAICS

541715

Signed Date

Sep 24, 2026

Key Details

Dollars Obligated

$53,901

Base & All Options

$215,604

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

National Institutes of Health

NAICS Code

541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

Parent IDIQ (PIID)

75N91021D00020

Product Service Code

AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

ROCHESTER, MN

Description

PHARMACOKINETIC AND BIOAVAILABILITY STUDIES IN RATS WITH INVESTIGATIONAL CANCER CHEMOTHERAPEUTIC AGENTS

Context & Analysis

On Sep 24, 2026, Department of Health and Human Services obligated $53,901 to MAYO CLINIC for pharmacokinetic and bioavailability studies in rats with investigational cancer chemotherapeutic agents. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). Competition extent: full and open competition with 3 offers received. Performance is located in ROCHESTER, MN. The contract is scheduled through Sep 27, 2027 — approximately 11 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.